Designed mimics of islet amyloid polypeptide as inhibitors of protein aggregation and cell degeneration in Alzheimer's disease and type 2 diabetes

被引:0
|
作者
Yan, L-M [1 ]
Velkova, A. [1 ]
Tatarek-Nossol, M. [2 ]
Kracklauer, M. [1 ]
Bakou, M. [1 ]
Andreetto, E. [1 ]
Kapurniotu, A. [1 ]
机构
[1] Tech Univ Munich, Div Peptide Biochem, Freising Weihenstephan, Germany
[2] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany
关键词
IAPP;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S56 / S57
页数:2
相关论文
共 50 条
  • [1] Islet amyloid polypeptide and type 2 diabetes
    Marzban, L
    Park, K
    Verchere, CB
    EXPERIMENTAL GERONTOLOGY, 2003, 38 (04) : 347 - 351
  • [2] Inhibition of Human Amyloid Polypeptide Aggregation and Membrane Damage in β-Islet Cell Mimics
    Wilson, Brenan
    Heyl, Deborah L.
    BIOPOLYMERS, 2011, 96 (04) : 498 - 498
  • [3] Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes
    Scrocchi, LA
    Chen, Y
    Wang, F
    Han, K
    Ha, K
    Wu, L
    Fraser, PE
    LETTERS IN PEPTIDE SCIENCE, 2003, 10 (5-6): : 545 - 551
  • [4] Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes
    Louise A. Scrocchi
    Yan Chen
    Feng Wang
    Kyung Han
    Katherine Ha
    Ling Wu
    Paul E. Fraser
    Letters in Peptide Science, 2003, 10 : 545 - 551
  • [5] Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease
    Fawver, Janelle N.
    Ghiwot, Yonatan
    Koola, Catherine
    Carrera, Wesley
    Rodriguez-Rivera, Jennifer
    Hernandez, Caterina
    Dineley, Kelly T.
    Kong, Yu
    Li, Jianrong
    Jhamandas, Jack
    Perry, George
    Murray, Ian V. J.
    CURRENT ALZHEIMER RESEARCH, 2014, 11 (10) : 928 - 940
  • [6] The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer's diseases
    Alrouji, Mohammed
    Al-Kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Alexiou, Athanasios
    Papadakis, Marios
    Saad, Hebatallah M.
    Batiha, Gaber El-Saber
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [7] The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
    Mohammed Alrouji
    Hayder M. Al-Kuraishy
    Ali I. Al-Gareeb
    Athanasios Alexiou
    Marios Papadakis
    Hebatallah M. Saad
    Gaber El-Saber Batiha
    Diabetology & Metabolic Syndrome, 15
  • [8] Targeting Human Islet Amyloid Polypeptide Aggregation and Toxicity in Type 2 Diabetes: An Overview of Peptide-Based Inhibitors
    Saini, Rajneet Kaur
    Goyal, Deepti
    Goyal, Bhupesh
    CHEMICAL RESEARCH IN TOXICOLOGY, 2020, 33 (11) : 2719 - 2738
  • [9] A designed peptide nanomolar affinity inhibitor of protein aggregation in both Alzheimer's disease and type 2 diabetes
    Yan, L.-M.
    Velkova, A.
    Tatarek-Nossol, M.
    Andreetto, E.
    Kapurniotu, A.
    BIOPOLYMERS, 2007, 88 (04) : 531 - 531
  • [10] Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model
    Wijesekara, Nadeeja
    Ahrens, Rosemary
    Sabale, Miheer
    Wu, Ling
    Ha, Kathy
    Verdile, Giuseppe
    Fraser, Paul E.
    FASEB JOURNAL, 2017, 31 (12): : 5409 - 5418